Bacteriology of otitis media with effusion

The Journal of Laryngology and Otology
K B SriwardhanaK T Dunkin

Abstract

A study was undertaken to evaluate the prevalence and antibiotic susceptibility of bacteria present in the middle ear of patients with otitis media with effusion. Middle ear effusions (MEE), nasopharyngeal and throat swabs were obtained at operation and cultured for aerobic and anaerobic bacteria. Two hundred and fifty-nine effusions were obtained from 152 subjects examined. Haemophilus influenzae was isolated from 32 (12.3 per cent) effusions, Streptococcus pneumoniae from seven (2.7 per cent), Staphylococcus aureus from seven (2.7 per cent), Branhamella catarrhalis from one (0.4 per cent)--Group A beta haemolytic streptococci from one (0.4 per cent) and Staphylococcus epidermidis from three (1.9 per cent). The occurrence of respiratory pathogens in MEE reflected their prevalence in the upper respiratory tract. Significantly fewer children who had received antibiotics prior to surgery had organisms present in the MEE. Eight and a half per cent of H. influenzae and 64 per cent of B. catarrhalis were resistant to ampicillin. The present study confirms that bacteria are present in the middle ear in a significant number of patients with otitis media with effusion.

References

Sep 1, 1977·The Laryngoscope·G B Healy, D W Teele
Nov 1, 1978·The Journal of Pediatrics·K H RidingC S Poziviak
Jul 1, 1979·Archives of Otolaryngology·D J LimH G Birck
Dec 1, 1979·Social Science & Medicine. Medical Geography·M L Miller
Mar 1, 1978·The Annals of Otology, Rhinology, and Laryngology·M PersicoM Fradis
May 1, 1975·Archives of Otolaryngology·Y S LiuH G Birck
Mar 1, 1976·The Annals of Otology, Rhinology, and Laryngology·T PalvaP Karma
Apr 26, 1986·British Medical Journal·D T McLeodA Seaton
Apr 1, 1972·Antimicrobial Agents and Chemotherapy·C H O'CallaghanA H Shingler
Oct 1, 1974·The Journal of Laryngology and Otology·J ThemsenH K Kristensen
Jul 7, 1973·British Medical Journal·S R Bushby
Jul 1, 1973·Proceedings of the Society for Experimental Biology and Medicine·R H Alford
May 1, 1974·The American Journal of Medicine·A I Arieff, C A Chidsey
Jun 1, 1972·Archives of Otolaryngology·M Tos, K Bak-Pedersen
Sep 1, 1966·Archives of Otolaryngology·J Sade
Apr 1, 1967·The Laryngoscope·W L Draper
Sep 1, 1984·Journal of the Royal Society of Medicine·R MillsM McIntyre
May 1, 1980·The Annals of Otology, Rhinology & Laryngology. Supplement·D J LimH G Birck
Sep 1, 1980·The Journal of Pediatrics·E L Kaplan
Sep 1, 1952·The Laryngoscope·O W SUEHS
Jan 1, 1953·A.M.A. Archives of Otolaryngology·F L HARCOURT, A K BROWN
Jun 1, 1953·The Annals of Otology, Rhinology, and Laryngology·J T KING
May 24, 1958·British Medical Journal·P L MASTERSM LIKAR
Jun 1, 1958·The Annals of Otology, Rhinology, and Laryngology·B H SENTURIAE S BAUMANN
Apr 5, 1952·British Medical Journal·B DAWSON, K ZINNEMANN

❮ Previous
Next ❯

Citations

Sep 16, 2010·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·Kai-Li LiangJiun-Yih Shiao
Apr 1, 1996·Clinical Otolaryngology and Allied Sciences·A HintonL O'Keefe
Jun 19, 2019·The Cochrane Database of Systematic Reviews·Anna M ScottChris B Del Mar
Jan 23, 2013·The Pediatric Infectious Disease Journal·Thijs M A van DongenAnne G M Schilder
Jan 1, 1993·European Archives of Oto-rhino-laryngology : Official Journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : Affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery·P B van CauwenbergeK J Ingels

❮ Previous
Next ❯

Related Concepts

Related Feeds

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.